Study on the prevalence of dyslipidemia in type 2 diabetes mellitus
Keywords:Diabetes mellitus, Dyslipidaemia, Hypercholesterolemia, Lipid profile
Background: Diabetes mellitus is a common health problem globally. Dyslipidaemia is a major risk factor to develop cardiovascular disease in diabetics. They present study was undertaken to find out the prevalence of dyslipidaemia in type 2 diabetic patients.
Methods: The present study was a cross sectional study consisting of 46 (23 male and 23 female) known type 2 diabetes mellitus patients. Age, gender, duration of diabetes, body mass index (BMI) was recorder in all the diabetic patients. Fasting blood glucose levels, total cholesterol, triglycerides, HDL, LDL, VLDL levels were measured using standard methods and recorded.
Results: The average total cholesterol, triglycerides, LDL, HDL and VLDL were 200±42mg/dl, 169.62±89.79mg/dl, 132.45±36.38mg/dl,39.1±16.6mg/dl and 35.85±17.09mg/dl respectively. The incidence of occurrence of hypercholesterolemia was 58.6% and hypertriglyceridemia 36.9%. Increased levels of LDL were observed in 30 (65.2%) patients and reduced HDL was observed in 43 (93.4%) patients. The incidence rate of dyslipidaemia was higher in female diabetic patients when compared to male diabetic patients.Conclusions: Awareness on the dyslipidaemia and its risk factors should be provided to the type 2 diabetic patients as they are more prone to get cardiovascular disease and lipid profile also should be monitored regularly along with blood glucose levels.
Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitus-data from a developing region of the world. Diab Res Clinic Pract. 1999;43(1):67-4.
Parkhad S, Palve S. Early diagnosis of neuropathy in diabetic patients using nerve conduction studies. National J Physiol Pharm Pharmacol. 2014;4(2):158.
Vittal V, Shankar V, Kutty K, Kumar SA. An interventional study of physical activity on HbA1C and VO2max in type 2 diabetes mellitus. Indian J Physiol Pharmacol. 2016;60(1):76-81.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian council of medical research-India diabetes study. Diabetol. 2011;54(12):3022-7.
Kolhar U, Priyanka P. Study of serum lipid profile in type 2 diabetes mellitus patients and its association with diabetic nephropathy. Int J Adv Med. 2017;4(6):1513-6.
Haffner SM. Management of dyslipidemia in adults with diabetes. Diab Care. 1998;21(1):160-78.
O’Keefe JH, Miles JM, Harris WH, Moe RM, McCallister BD. Improving the adverse cardiovascular prognosis of type 2 diabetes. Mayo Clin Proc. 1999;74:171-80.
Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes dyslipidemia. Diab Therapy. 2016;7(2):203-19.
O'brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clinic Proceed. 1998;73(10);969-76.
NCEP. Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-97. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11368702.
Pandya H, Lakhani JD, Dadhania J, Trivedi A. The prevalence and pattern of dyslipidemia among type 2 diabetic patients at rural based hospital in Gujarat, India. Indian J Clinic Pract. 2012;22(12):36-44.
Tagoe DN, Amo-Kodieh P. Type 2 diabetes mellitus influences lipid profile of diabetic patients. Annals Bio Res. 2013;4(6):88-92.
Jayarama N, Reddy M, Raj SD. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients in a rural tertiary care centre, southern India. Glob J Med Public Health. 2012;1:24-8.
Singh G, Kumar AK. A study of lipid profile in type 2 diabetic Punjabi population. J Exerc Sci Physioth. 2012;8(1):7.
Bali K, Vij AK. Pattern of dyslipidaemia in type 2 diabetes mellitus in Punjab. Int J Res Med Sci. 2016;4(3):809-1.
Pathak LA, Shirodkar S, Ruparelia R, Rajebahadur J. Coronary artery disease in women. Indian Heart J. 2017;69(4):532-8.
Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. New Eng J Med. 1989;321(10):641.
Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturit. 1999;33(3):259-69.
Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham study. Annals Int Med. 1971;74(1):1-2.